Association between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Characteristics of Plaque Rupture
Rattachement africain : jp, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
AIMS: Eicosapentaenoic acid (EPA) has shown beneficial effects on coronary plaque stabilization. Based on our previous study, we speculated that EPA might be associated with the development of healed plaques and might limit thrombus size. This study aimed to elucidate the association between EPA and arachidonic acid (AA) ratios and various plaque characteristics in patients with plaque rupture. METHODS: A total of 95 patients with acute coronary syndrome (ACS) caused by plaque rupture who did not take lipid-lowering drugs and underwent percutaneous coronary intervention using optical coherence tomography (OCT) were included. Clinical characteristics, lipid profiles, and OCT findings were compared between patients with lower and higher EPA/AA ratios (0.41) according to the levels in the Japanese general population. RESULTS: In the high EPA/AA (n=29, 30.5%) and low EPA/AA (n=66, 69.5 %) groups, the high EPA/AA group was significantly older (76.1 vs. 66.1 years, P＜0.01) and had lower peak creatine kinase (556 vs. 1651 U/L, P=0.03) than those with low EPA/AA. Similarly, patients with high EPA/AA had higher prevalence of layered and calcified plaque (75.9 vs. 39.4 %, P＜0.01; 79.3 vs. 50.0 %, P＜0.01, respectively) than low EPA/AA group. Multivariate logistic regression analysis demonstrated that a high EPA/AA ratio was an independent factor in determining the development of layered and calcified plaques. CONCLUSION: A high EPA/AA ratio may be associated with the development of layered and calcified plaques in patients with plaque rupture.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Association between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Characteristics of Plaque Rupture
- Date Crossref
- 01/11/2023
- Éditeur
- Japan Atherosclerosis Society
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
SHOWA Medical University pays non établi dans la noticeUniversité ou école supérieure
-
SHOWA Medical University Fujigaoka Hospital pays non établi dans la noticeÉtablissement de santé
-
Therapeutics Clinical Research pays non établi dans la noticeStructure de recherche
-
Showa University Fujigaoka Hospital Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Showa University School of Medicine Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Showa University School of Dentistry Department of Perioperative Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Clinical Research Institute for Clinical Pharmacology and Therapeutics Showa University pays non établi dans la noticeUniversité ou école supérieure
SHOWA Medical University, SHOWA Medical University Fujigaoka Hospital et Therapeutics Clinical Research, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.